RxDoctor Payments Data

Bradley Hatcher, NP

Family · Dunlap, TNNPI 1740612878

Payments from drug & device makers

$490in general payments, 2019–2025

Across 28 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$119
  • AstraZeneca$55
  • Sequel Med Tech, LLC$51
  • Novo Nordisk$51
  • Bayer$37
  • Novartis$25
  • plus $152 from 9 others

What the payments were for

  • Food & beverage$490100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$490 in reported general payments places this provider in the 50th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$202,196
Medicare patients
291
Services billed
2,715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban24$16,323
JardianceEmpagliflozin14$14,532
JanuviaSitagliptin Phosphate13$11,629
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,165
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,862
Tresiba Flextouch U-100Insulin Degludec15$6,626
Clorazepate Dipotassium22$1,859
Potassium Chloride83$1,622
Memantine Hcl ErMemantine Hcl14$1,561
Pantoprazole Sodium144$1,344
Montelukast Sodium142$1,144
Gabapentin111$1,044
Albuterol Sulfate HfaAlbuterol Sulfate38$1,024
Ezetimibe30$906
Metoprolol Succinate65$861

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere$55$6,86211 claims
AbbVieSynthroid$119$82012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,706 family providers in Tennessee.

Other family in Dunlap

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →